Role of the Systemic Inflammatory Response Index in Predicting Disease Severity and Prognosis in Idiopathic Pulmonary Arterial Hypertension
Luyang Gao,Sicheng Zhang,Zhihui Zhao,Qing Zhao,Tao Yang,Qixian Zeng,Yi Zhang,Xin Li,Zhihua Huang,Anqi Duan,Qin Luo,Zhihong Liu
DOI: https://doi.org/10.2147/jir.s434720
IF: 4.5
2024-01-23
Journal of Inflammation Research
Abstract:Luyang Gao, &ast Sicheng Zhang, &ast Zhihui Zhao, Qing Zhao, Tao Yang, Qixian Zeng, Yi Zhang, Xin Li, Zhihua Huang, Anqi Duan, Qin Luo, Zhihong Liu Center for Respiratory and Pulmonary Vascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, National Clinical Research Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhihong Liu; Qin Luo, Center for Respiratory and Pulmonary Vascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, National Clinical Research Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 167 Beilishi Road, Xicheng District, Beijing, 100037, People's Republic of China, Tel/Fax +86-010-88396589, Email ; Introduction: Mounting evidence indicates a possible connection between the systemic inflammatory response index (SIRI) and the prognosis of heart failure, but its role in idiopathic pulmonary arterial hypertension (IPAH) is not well understood. This study aimed to investigate the relationship between SIRI and variables such as functional ability, echocardiography results, hemodynamic measurements, and long-term outcomes in patients with IPAH. Methods: The study included 426 consecutive IPAH patients who underwent right heart catheterization at Fuwai Hospital from January 2013 to December 2020. SIRI was calculated using composite inflammation indicators from routine blood tests. The main outcome measure was clinical deterioration. Spearman correlation coefficients were used to assess associations between SIRI and indicators of IPAH severity. Receiver operating characteristic (ROC) curve analysis was conducted to determine the optimal SIRI threshold and predictive ability. Kaplan-Meier analysis and Cox proportional hazard models were used to examine the relationship between SIRI and clinical deterioration. Results: SIRI showed positive associations with indicators such as N-terminal pro-brain natriuretic peptide, right ventricular end-diastolic diameter, pericardial effusion, mean pulmonary arterial pressure, and pulmonary vascular resistance. Conversely, SIRI had inverse relationships with 6-minute walking distance and left ventricular end-diastolic diameter. Kaplan-Meier curves revealed a significantly higher rate of clinical deterioration in individuals with SIRI > 0.741 compared to those with SIRI ≤ 0.741 (P < 0.001). Adjusted Cox analysis showed SIRI remained an independent predictor of clinical worsening (hazard ratio 1.366, 95% confidence interval 1.073– 1.738, P = 0.011). ROC analysis demonstrated SIRI provided additional predictive value beyond the risk assessment score of the European Society of Cardiology/European Respiratory Society. Discussion: In summary, SIRI could predict the severity and prognosis of IPAH independently. It was associated with various indicators of IPAH severity and was a significant predictor of clinical deterioration. SIRI also offered additional predictive value beyond existing risk assessment scores. Keywords: prognosis, pulmonary arterial hypertension, risk factor, systemic inflammatory response index Pulmonary arterial hypertension (PAH) is characterized by a gradual escalation in both pulmonary artery pressure and pulmonary vascular remodeling. It signifies the end stage of various cardiopulmonary conditions, leading to right-sided heart failure and death. 1 The outlook for this ailment is bleak, and individuals face significant financial strain. Consequently, clinicians should identify individuals with PAH who may be at elevated risk of mortality. To offer improved clinical guidance, it is advisable to utilize risk stratification and clinical markers that can anticipate the severity and prognosis of the disease. The development of PAH is intricate and not well comprehended. PAH development is associated with hemodynamic abnormalities, genetic mutations, epigenetic dysregulation, oxidative stress, immune reactions, inflammation, and fibrosis, as indicated by prior research. 2,3 Multiple research studies have examined the correlation between markers of inflammation and PAH. C-reactive protein (CRP) and the ratio of CRP to albumin are strongly linked to the clinical outcomes of patients with PAH and their responses to targeted pharmacotherapy. 4,5 The clinical outcomes of PAH patients and their responses to targeted drugs are significantly associated with CRP and the CRP to albumin ratio. Additionally, the pro-inflammatory proteins, cytokines interleukin-6 and stromal-derived factor alpha are strongly linked to worsening hemodynamics -Abstract Truncated-
immunology